Clinical trials
Completed Myotonic Dystrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut de Myologie, France | 4 |
| University of Rochester | 4 |
| Avidity Biosciences, Inc. | 3 |
| LMU Klinikum | 3 |
| AMO Pharma Limited | 2 |
| Lupin Ltd. | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| CHU de Reims | 1 |
| Catholic University of the Sacred Heart | 1 |
| Centre d'Investigation Clinique et Technologique 805 | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myotonic Dystrophy | 54 |
| Myotonic Disorders | 6 |
| Muscular Diseases | 5 |
| Muscular Dystrophies | 5 |
| Neuromuscular Diseases | 5 |
| Disorders of Excessive Somnolence | 4 |
| Genetic Diseases, Inborn | 3 |
| Muscular Dystrophy, Facioscapulohumeral | 3 |
| Heredodegenerative Disorders, Nervous System | 2 |
| Huntington Disease | 2 |
Trials
Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.